Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Share-based Compensation (2019 - 2026)

Outset Medical has reported Share-based Compensation over the past 7 years, most recently at $4.1 million for Q4 2025.

  • Quarterly Share-based Compensation fell 17.84% to $4.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $15.6 million through Dec 2025, down 46.8% year-over-year, with the annual reading at $15.6 million for FY2025, 46.8% down from the prior year.
  • Share-based Compensation was $4.1 million for Q4 2025 at Outset Medical, down from $5.1 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $10.9 million in Q3 2023 and troughed at $2.9 million in Q3 2021.
  • The 5-year median for Share-based Compensation is $6.1 million (2021), against an average of $6.4 million.
  • The largest YoY upside for Share-based Compensation was 908.97% in 2021 against a maximum downside of 78.63% in 2021.
  • A 5-year view of Share-based Compensation shows it stood at $4.8 million in 2021, then soared by 53.44% to $7.4 million in 2022, then grew by 23.73% to $9.1 million in 2023, then tumbled by 45.65% to $4.9 million in 2024, then dropped by 17.84% to $4.1 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Share-based Compensation are $4.1 million (Q4 2025), $5.1 million (Q3 2025), and $3.5 million (Q2 2025).